Clinical trial NCT01460680 - References

Fibromyalgia — Membrane Polyunsaturated Fatty Acid Content in Fibromyalgia and Systemic Lupus Erythematosus (SLE)

Citation(s)

•   Arnold LM
  The pathophysiology, diagnosis and treatment of fibromyalgia. Psychiatr Clin North Am. 2010 Jun;33(2):375-408. doi: 10.1016/j.psc.2010.01.001. Review.
•   Maes M, Smith R, Christophe A, Cosyns P, Desnyder R, Meltzer H
  Fatty acid composition in major depression: decreased omega 3 fractions in cholesteryl esters and increased C20: 4 omega 6/C20:5 omega 3 ratio in cholesteryl esters and phospholipids. J Affect Disord. 1996 Apr 26;38(1):35-46.
•   Riemer S, Maes M, Christophe A, Rief W
  Lowered omega-3 PUFAs are related to major depression, but not to somatization syndrome. J Affect Disord. 2010 Jun;123(1-3):173-80. doi: 10.1016/j.jad.2009.08.004. Epub 2009 Aug 31.
•   Shapiro H
  Could n-3 polyunsaturated fatty acids reduce pathological pain by direct actions on the nervous system? Prostaglandins Leukot Essent Fatty Acids. 2003 Mar;68(3):219-24. Review.
•   Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, et al
  The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990 Feb;33(2):160-72.

Association of Membrane Polyunsaturated Fatty Acid Content and Intracellular Magnesium Concentration With Mental and Physical Symptoms in Fibromyalgia and SLE: a Case-control Study

Details for clinical trial NCT01460680